Prophylactic methylxanthines for extubation in preterm infants

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Henderson Smart, David J ^a   Davis, Peter G ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Caffeine therapeutic use ; Central nervous system agents *therapeutic use ; Diseases *prevention control ; Infant, newborn; Infant, premature; Intermittent positive pressure ventilation; Intubation, intratracheal; Randomized controlled trials as topic; Theophylline therapeutic use ; Time factors; Vasodilator agents *therapeutic use ; Ventilator weaning; Xanthines therapeutic use

Indexed keywords

AMINOPHYLLINE; CAFFEINE; CAFFEINE CITRATE; METHYLXANTHINE; PLACEBO; THEOPHYLLINE;

BIRTH WEIGHT; BREATHING EXERCISE; CLINICAL TRIAL; EXTUBATION; GESTATIONAL AGE; HUMAN; INTERMITTENT POSITIVE PRESSURE VENTILATION; LOADING DRUG DOSE; LOW BIRTH WEIGHT; LUNG COMPLIANCE; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME;

EID: 77950110585     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000139     Document Type: Review

References (25)

1. Barrington 1993 {published and unpublished data} * Barrington KJ, Finer NN. A randomized controlled trial of aminophylline in ventilatory weaning of premature infants. Critical Care Medicine 1993;21:846-50.
2. Barrington KJ, Finer NN. A randomized controlled trial of aminophylline in ventilatory weaning of premature infants. Pediatric Research 1992;31:342A.
3. Durand 1987 {published data only} * Durand DJ, Goodman A, Ray P, Ballard RA, Clyman RI. Theophylline treatment in the extubation of infants weighing less than 1,250 grams: a controlled trial. Pediatrics 1987;80:684-8.
4. Piecuch RE, Leonard CH, Ballard RA, Clyman RI. Neurodevelopmental outcome of very low birthweight VLBW=<1000g) infants treated with theophylline (T) to facilitate extubation. Pediatric Research 1989;25:261A.
5. Greenough 1985 {published data only} Greenough A, Elias-Jones A, Pool J, Morley CJ, Davis JA. The therapeutic actions of theophylline in preterm ventilated infants. Early Human Development 1985;12:15-22.
6. Muro 1992 {published data only} * Muro M. Pharmacological treatment during the weaning of mechanical ventilation in preterm infants. Effects on pulmonary mechanics [Tratamiento farmacológico en la retirada de la ventilación mecánica del recién nacido pretérmino. Repercusión sobre la función pulmonar]. Tesis doctoral, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid 1992.
7. Muro M, Perez-Rodriguez J, Garcia MJ, Arroyo I, Quero J. Efficacy of caffeine for weaning premature infants from mechanical ventilation. Effects on pulmonary function. Journal of Perinatal Medicine 1992;20:315.
8. Pearlman 1991 {published data only} * Pearlman SA, Kepler JA, Stefano JL. Comparative efficacy of theophylline and caffeine in facilitating extubation of preterm infants with respiratory distress syndrome. Unpublished manuscript written in 1991, provided by author.
9. Pearlman SA, Stefano JL. Caffeine (C) vs theophylline (T) to facilitate extubation in preterm infants with RDS. Proceedings of the European Society for Paediatric Research. 1991:362.
10. Viscardi 1985 {published data only} Viscardi RM, Faix RG, Nicks JJ, Grasela TH. Efficacy of theophylline for prevention of post-extubation respiratory failure in very low birth weight infants. Journal of Pediatrics 1985;107: 469-72.
11. CAP Trial 2006 {published data only} Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. New England Journal of Medicine 2006;354(20):2112-21.
12. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A. Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. New England Journal of Medicine 2007;357(19): 1893-902.
13. Blanchard 1992 Blanchard PW, Aranda JV. Pharmacotherapy of respiratory control disorders. In: Beckerman RC, Brouillette RT, Hunt CE editor(s). Respiratory Control Disorders in Infants and Children. Baltimore: Williams & Wilkins, 1992:161-77.
14. Davis 2000 Davis P, Doyle L, Rickards A, Kelly E, Ford G, Davis N, Callanan C. Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight. Journal of Paediatric and Child Health 2000;36:47-50.
15. Davis 2001 PG Davis, DJ Henderson-Smart. Extubation from low-rate intermittent positive airways pressure versus extubation after a trial of endotracheal continuous positive airways pressure in intubated preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD001078]
16. Davis 2003 PG Davis, DJ Henderson-Smart. Intravenous dexamethasone for extubation of newborn infants. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: DOI: 10.1002/14651858.CD000308]
17. Davis 2003a Davis PG, Henderson-Smart DJ. Nasal continuous positive airway pressure immediately after extubation for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD000143]
18. Henderson-Smart 2005 Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: DOI: 10.1002/14651858.CD000140]
19. Henderson-Smart 1999 Henderson-Smart DJ, Steer P. Prophylactic methylxanthine for the prevention of apnea in preterm infants. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: DOI: 10.1002/14651858.CD000432]
20. Henderson-Smart 2000 Henderson-Smart DJ, Davis PG. Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD001966]
21. Henderson-Smart 2004 Henderson-Smart DJ. Recurrent apnoea. Evidence Based Pediatrics. Oxford: Blackwell, 2004.
22. Steer 1998 Steer PA, Henderson-Smart DJ. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: DOI: 10.1002/14651858.CD000273]
23. Henderson-Smart 1998 Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 1. [Art. No.: CD000139. DOI: 10.1002/14651858.CD000139]
24. Henderson-Smart 2003 Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 1. [Art. No.: CD000139. DOI: 10.1002/14651858.CD000139]
25. Henderson-Smart 2006 Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database of Systematic Reviews 2006, Issue 1. [Art. No.: CD000139. DOI: 10.1002/14651858.CD000139]